Ro Company Overview and Business Strategy

Ro is a company that offers a platform for buying and selling used items, with a focus on making the process easy and efficient. Founded in 2014, Ro has grown to become a popular destination for people looking to declutter their homes and make some extra cash.

Ro's business strategy is centered around its online marketplace, where users can list and purchase items from a wide range of categories. With a strong focus on user experience, Ro has built a reputation for being a trustworthy and reliable platform.

Ro has raised a total funding of $1.03 billion over 7 rounds, with its first funding round happening on August 3, 2017. Its latest funding round was a Series D round on February 15, 2022, for $150 million.

Ro has 11 investors participating in its latest funding round, led by ShawSpring. The company's 37 institutional investors include General Catalyst, FirstMark, and ShawSpring. Scott Belsky and 3 others are Angel Investors in Ro.

Consider reading: Round 2 (company)

Ro's funding rounds have resulted in post-money valuations of $7 billion and $5 billion, respectively. The company has received investments from a range of venture capital firms, including General Catalyst, TQ Ventures, and SignalFire.

Ro has raised a total funding of $1.03 billion over 7 rounds, with its first funding round taking place on August 3, 2017.

Its latest funding round was a Series D round on February 15, 2022, for $150 million, led by ShawSpring, with 11 investors participating.

Ro has 37 institutional investors, including General Catalyst, FirstMark, and ShawSpring. Scott Belsky and 3 others are Angel Investors in Ro.

Here's a breakdown of Ro's funding rounds:

Ro's investments and acquisitions have been a significant focus for the company in recent years. Ro acquired Dadi in March 2022, expanding its reach in the healthcare industry.

The acquisition of Dadi in 2022 was not the only notable investment for Ro. In 2021, the company made two major acquisitions, starting with Kit in June. Kit offers at-home diagnostic tests, including finger prick blood tests and weight measurement tools.

Broaden your view: Ubs Mergers and Acquisitions

Ro's acquisition of Kit in June 2021 was a strategic move to expand its services. Modern Fertility, another company acquired by Ro in 2021, focuses on women's reproductive health.

Here are some key details about Ro's investments and acquisitions:

Ro's corporate structure is made up of multiple entities, indicating a complex organizational setup.

One of these entities is Modern Health, Inc., which is a legal entity associated with Ro.

Here are some key details about the entities associated with Ro:

Note that the employee counts for some of these entities are only available for specific dates, which may indicate fluctuations in the workforce over time.

Let's dive into the legal entities associated with Roman Health. The company has multiple entities, each with its own date of incorporation and status.

The first entity is MODERN HEALTH, INC, which is a United States-based company that is still active.

Roman Health Ventures, Inc. was incorporated on August 26, 2021, and is also an active company.

There are two entities named ROMAN HEALTH PHARMACY LLC, each with different dates of incorporation: February 1, 2023, and July 19, 2020.

Here's a breakdown of the entities with their respective dates of incorporation and statuses:

One of the entities, Roman Health Ventures, Inc. (CIN: 32075155534), has a notable employee count, with 496 employees as of December 31, 2023.

The founders and board of directors play a crucial role in shaping the company's vision and direction.

Zachariah Reitano is the Co-Founder & CEO of Ro, and he's also the founder of another company. He's an angel investor in one startup and serves on the board of another company.

Rob Schutz is the Co-Founder of Ro and has founded one other company. He also serves on the board of one company.

Saman Rahmanian is the Co-Founder & CPO of Ro and has founded one other company. Like the others, she serves on the board of one company.

Here's a quick rundown of the founders and board of directors:

Ro's acquisitions are a key part of its growth strategy, and the company has been making some big moves in the past couple of years.

In December 2020, Ro acquired WorkPath, a company that sends phlebotomists into patient homes to draw blood for diagnostic tests. This acquisition shows Ro's commitment to expanding its services and making healthcare more accessible to patients.

Ro's acquisition of Modern Fertility in May 2021 was a significant deal, valued at over $225 million. This acquisition marked a major expansion into women's reproductive health.

Ro also acquired Kit, a startup offering at-home diagnostic tests, in June 2021. Kit's finger prick blood tests and weight measurement tools will likely complement Ro's existing services.

Here are some key details about Ro's acquisitions:

Ro is a company that operates in the United States and is available in many states.

Ro has a strong online presence, with a user-friendly website and mobile app that allows customers to order prescriptions and other healthcare products.

Ro's market presence is further amplified by its partnerships with various healthcare providers and pharmacies.

Ro has made significant strides in research, particularly in the realm of telehealth.

The company partnered with the National Institute on Aging in October 2022 to create a registry of patients for future Alzheimer's disease research and clinical trials.

Ro has also published research on various telehealth topics, including a study that found comparable rates of side effects between asynchronous and synchronous virtual care.

In the digital health space, Ro is not the only player in town. Let's take a look at some of its competitors and alternates.

Ro's main competitor is Amwell, which has been around since 2006 and has a public funding of $887M. Amwell provides telehealth and consultation solutions for doctors and patients.

Ro's overall rank is 1st, but Amwell is close behind at 2nd. Interestingly, both Ro and Amwell have the same Tracxn Score of 78/100.

Here's a list of the top 10 competitors and alternates in the digital health space, ranked by their overall rank:

These competitors and alternates are all vying for a piece of the digital health pie, and it's worth noting that some of them, like Ro and Amwell, have a significantly higher total funding than the others.

Ro offers a one-month discounted cash price of $199 for Wegovy for new patients. This is a great opportunity for those who need this medication.

Ro is able to offer this discounted price through a partnership with Novo Nordisk.

On a similar theme: Regions Financial Corporation Stock Price